These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29169729)

  • 1. miR-193b-3p possesses anti-tumor activity in ovarian carcinoma cells by targeting p21-activated kinase 3.
    Zhang J; Qin J; Su Y
    Biomed Pharmacother; 2017 Dec; 96():1275-1282. PubMed ID: 29169729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells.
    Lin SR; Yeh HC; Wang WJ; Ke HL; Lin HH; Hsu WC; Chao SY; Hour TC; Wu WJ; Pu YS; Huang AM
    J Cell Biochem; 2017 Jun; 118(6):1563-1573. PubMed ID: 27918099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis.
    Wang J; Ye C; Liu J; Hu Y
    Biochem Biophys Res Commun; 2018 Jul; 501(4):1034-1040. PubMed ID: 29777711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation-associated silencing of
    Chen K; Liu MX; Mak CS; Yung MM; Leung TH; Xu D; Ngu SF; Chan KK; Yang H; Ngan HY; Chan DW
    Theranostics; 2018; 8(2):423-436. PubMed ID: 29290818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-205-3p Functions as a Tumor Suppressor in Ovarian Carcinoma.
    Qiao B; Wang Q; Zhao Y; Wu J
    Reprod Sci; 2020 Jan; 27(1):380-388. PubMed ID: 32046433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-223-3p Regulates Ovarian Cancer Cell Proliferation and Invasion by Targeting SOX11 Expression.
    Fang G; Liu J; Wang Q; Huang X; Yang R; Pang Y; Yang M
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-342-3p inhibits cell migration and invasion through suppressing forkhead box protein Q1 in ovarian carcinoma.
    Wang C; Zhang W; Xing S; Wang Z; Wang J; Qu J
    Anticancer Drugs; 2019 Oct; 30(9):917-924. PubMed ID: 31517731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-506-3p suppresses the proliferation of ovarian cancer cells by negatively regulating the expression of MTMR6.
    Wang Y; Lei X; Gao C; Xue Y; Li X; Wang H; Feng Y
    J Biosci; 2019 Dec; 44(6):. PubMed ID: 31894107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of microRNA-193-3p inhibits tumor proliferation migration and chemoresistance in human gastric cancer by regulating PTEN gene.
    Jian B; Li Z; Xiao D; He G; Bai L; Yang Q
    Tumour Biol; 2016 Jul; 37(7):8941-9. PubMed ID: 26753960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells.
    Miyamoto M; Sawada K; Nakamura K; Yoshimura A; Ishida K; Kobayashi M; Shimizu A; Yamamoto M; Kodama M; Hashimoto K; Kimura T
    Sci Rep; 2020 Oct; 10(1):16755. PubMed ID: 33028939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircATL2 enhances paclitaxel resistance of ovarian cancer via impacting miR-506-3p/NFIB axis.
    Ying H; Zhao R; Yu Q; Zhang K; Deng Q
    Drug Dev Res; 2022 Apr; 83(2):512-524. PubMed ID: 34541682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulated expression of miR-134 contributes to paclitaxel resistance in human ovarian cancer cells.
    Shuang T; Wang M; Shi C; Zhou Y; Wang D
    FEBS Lett; 2015 Oct; 589(20 Pt B):3154-64. PubMed ID: 26363097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
    Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
    Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-378a-3p sensitizes ovarian cancer cells to cisplatin through targeting MAPK1/GRB2.
    Xu ZH; Yao TZ; Liu W
    Biomed Pharmacother; 2018 Nov; 107():1410-1417. PubMed ID: 30257357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MORC4 is a novel breast cancer oncogene regulated by miR-193b-3p.
    Yang Z; Zhuang Q; Hu G; Geng S
    J Cell Biochem; 2019 Mar; 120(3):4634-4643. PubMed ID: 30320920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells.
    Báez-Vega PM; Echevarría Vargas IM; Valiyeva F; Encarnación-Rosado J; Roman A; Flores J; Marcos-Martínez MJ; Vivas-Mejía PE
    Oncotarget; 2016 Jun; 7(24):36321-36337. PubMed ID: 27166999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4).
    Wang G; Sun Y; He Y; Ji C; Hu B; Sun Y
    Int J Clin Exp Pathol; 2015; 8(1):337-44. PubMed ID: 25755720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-193b promotes cell proliferation by targeting Smad3 in human glioma.
    Zhong Q; Wang T; Lu P; Zhang R; Zou J; Yuan S
    J Neurosci Res; 2014 May; 92(5):619-26. PubMed ID: 24496888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced up-regulation of miR-27a promotes paclitaxel resistance in ovarian cancer.
    Feng L; Shen F; Zhou J; Li Y; Jiang R; Chen Y
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32190895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. let-7d-3p is associated with apoptosis and response to neoadjuvant chemotherapy in ovarian cancer.
    García-Vázquez R; Gallardo Rincón D; Ruiz-García E; Meneses García A; Hernández De La Cruz ON; Astudillo-De La Vega H; Isla-Ortiz D; Marchat LA; Salinas-Vera YM; Carlos-Reyes Á; López-González S; Ramos-Payan R; López-Camarillo C
    Oncol Rep; 2018 Jun; 39(6):3086-3094. PubMed ID: 29658612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.